Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients.

Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients. Abstract Text:

    hyun-jung choHyun-Jung Cho,kie-ho sohnKie-Ho Sohn,hyang-mi parkHyang-Mi Park,kyung-hoon leeKyung-Hoon Lee,boyoung choiBoYoung Choi,seonwoo kimSeonwoo Kim,june-soo kimJune-Soo Kim,young-keun onYoung-Keun On,mi-ryung chunMi-Ryung Chun,hee-jin kimHee-Jin Kim,jong-won kimJong-Won Kim,soo-youn leeSoo-Youn Lee,

    INTRODUCTION: Warfarin, a commonly prescribed anticoagulant, exhibits large interindividual and interethnic differences in the dose required for its anticoagulation effect. Asian patients require a much lower maintenance dose compared with Caucasians; the explanation for these differences remains unknown. METHODS: We analyzed five single nucleotide polymorphisms of the vitamin K epoxide reductase complex subunit 1 gene (VKORC1) and the *3 variant of cytochrome P450 (CYP)2C9, as well as the plasma warfarin concentration, in 108 Korean patients with atrial fibrillation. RESULTS: Genotypic frequencies of VKORC1 +1173CT and CYP2C9*1/*3 were 17.6 and 10.2%, respectively, in the study population; VKORC1 +1173CC and CYP2C9*3/*4 were detected in one patient each. Patients carrying at least one copy of the VKORC1 +1173C allele, or the H7 (group B) haplotype, required a significantly higher warfarin dose (n = 20; 5.5 +/- 1.7 mg/day) than those homozygous for the +1173T allele, or the H1 (group A) haplotype, (3.8 +/- 1.2 mg/day; p < 0.001). There were statistically significant differences in warfarin dose between the CYP2C9*1/*1 (4.3 +/- 1.6 mg/day; p < 0.001) and those with the other two genotypes including CYP2C9*1/*3 and CYP2C9*3/*4 (2.7 +/- 0.9 mg/day). The multiple regression analysis revealed that the VKORC1 genotype (r2 = 0.197; p < 0.001), the age when warfarin started (r2 = 0.09; p < 0.001), body surface area (r2 = 0.041; p = 0.004) and CYP2C9 genotype (r2 = 0.029; p = 0.014) were factors associated with the daily dose of warfarin required. CONCLUSION: In the present study, we found that the VKORC1 polymorphism had a dominant genetic influence on interindividual variability for warfarin dose in Korean patients. It explained approximately 32% of the overall variability in warfarin dose requirements given all of the variables studied. Thus, analysis of the VKORC1 genotypes may be important to guide warfarin dose selection and allow personalized warfarin treatment.

    Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients. Publishing Authors By Initials

    hj choHJ Cho,kh sohnKH Sohn,hm parkHM Park,kh leeKH Lee,b choiB Choi,s kimS Kim,js kimJS Kim,yk onYK On,mr chunMR Chun,hj kimHJ Kim,jw kimJW Kim,sy leeSY Lee,

    For similar heterocyclic compounds: heterocyclic compounds, 2-ring: benzopyrans: coumarins: 4-hydroxycoumarins: warfarin research abstracts see: heterocyclic compounds: heterocyclic compounds, 2-ring: benzopyrans: coumarins: 4-hydroxycoumarins: warfarin research

    PUBMED ID PMID:

    MEDLINE DATE:

    Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Pharmacogenomics

    VOLUME: 8

    Page Numbers: 329-37

    Journal Abbreviation: Pharmacogenomics

    ISSN: 1744-8042

    DAY: 30

    MONTH: Apr

    YEAR: 2007

    Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100897350

    Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients. Keywords Mesh Terms:

    KEYWORDS: Warfarin

    MESH TERMS: adverse effects

    Chemical & Substance for Abstract: Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients. Information

    Substance Name: Cytochrome P-450 Enzyme System

    Registry Number: 9035-51-2

    Grant and Affiliation Information for Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients.

    AFFILIATION: Sungkyunkwan University School of Medicine, Department of Laboratory Medicine, Samsung Medical Center, 50 Irwon-dong, Gangnam-gu, Seoul, 135-710, Korea.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Pharmacogenomics

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News